Chapel Hill, NC — November 17, 2008 — Blair Keagy, MD, CEO, is pleased to announce the launch of
MPAnalytics, Inc. - a medical consultant group dedicated to helping businesses
evaluate the commercial potential of new medical products and technologies.
MPAnalytics provides market analysis and recommendations
for new medical devices and technology based on five key parameters: scientific
merit, reimbursement potential, competition and clinical potential, practical
market potential and clinical trial analysis. The founders of MPAnalytics have
extensive clinical experience as well as knowledge of clinical trial design,
reimbursement issues and practical markets for new medical devices and
technologies.
Dr. Blair Keagy, former Chief of Vascular Surgery at
the
“I credit my colleagues at the UNC School of
Medicine and the Kenan-Flaghler Launching the Venture
Program with helping to get this business off the ground” states Dr. Keagy. “Now, we have clients enthusiastically soliciting
our help in assessing the business potential of their new medical devices or
ideas before investing significant monies in development or clinical trial.”
Ted Zoller, Executive
Director,
The MPAnalytics team combines their
competence in medical research and the life sciences marketplace with the
business savvy necessary to create a medical consultant group that provides
great value to medical device companies and investor groups.
For more information about MPAnalytics,Inc. please contact
Blair Keagy at bkeagy@mpanalytics.com or call
919.873.4047.